TRANSLATIONAL DRUG DEVELOPMENT, LLC – Trademark Portfolio
Entity Type: 16
TRANSLATIONAL DRUG DEVELOPMENT, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include TD2, TD2 PRECISION ONCOLOGY, and THE PRECISION ONCOLOGY CRO. The owner is based in SCOTTSDALE, AZ.
13208 EAST SHEA BOULEVARD
SUITE 100
SCOTTSDALE, AZ 85259
Showing of trademarks Trademarks
Trademark Classifications
TRANSLATIONAL DRUG DEVELOPMENT, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does TRANSLATIONAL DRUG DEVELOPMENT, LLC have?
TRANSLATIONAL DRUG DEVELOPMENT, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 2 cancelled.
What trademark classes does TRANSLATIONAL DRUG DEVELOPMENT, LLC file in?
TRANSLATIONAL DRUG DEVELOPMENT, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What are TRANSLATIONAL DRUG DEVELOPMENT, LLC's most well-known trademarks?
TRANSLATIONAL DRUG DEVELOPMENT, LLC's registered trademark portfolio includes well-known marks such as TD2, TD2 PRECISION ONCOLOGY, and THE PRECISION ONCOLOGY CRO. These are among 3 currently registered trademarks in the portfolio.
What is TRANSLATIONAL DRUG DEVELOPMENT, LLC's trademark registration success rate?
TRANSLATIONAL DRUG DEVELOPMENT, LLC has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.